Pharmaceuticals
Latest

Pharmaceuticals
From Devastation to Popping Champagne: Reata Pharmaceuticals’ Roller Coaster Year
The Plano-based drug company halted work on years of research this year while celebrating a major achievement.
By Will Maddox

marijuana
Texas Is Likely to Expand Medicinal Marijuana Laws, But Access Is Still an Issue
Texas law says the medicine can only be stored in one location, meaning patients sometimes have to wait for weeks for their prescriptions.
By Will Maddox

Pharmaceuticals
Signify Health CEO Kyle Armbrester on What’s Next After CVS’ $8 Billion Acquisition
Signify will be staying in Dallas, growing, and diversifying, he says. "This is not about cost-cutting."
By Will Maddox

Pharmaceuticals
Texas Pharmacists Want to Keep Their Expanded Vaccination Capabilities
Advocates are pushing for a law to codify pandemic-era changes, but pediatricians say kids need to get vaccinations from their medical home.
By Will Maddox

Pharmaceuticals
Mark Cuban: Business Is How We Teach Washington What Works
At the Dallas Regional Chamber's annual meeting, he discussed how his pharmaceutical company is doing to drug prices what government regulation has been unable to do.
By Will Maddox
Advertisement
Latest

Pharmaceuticals
Mark Cuban’s Drug Company Has Entered the Employer Market
Cost Plus is partnering with a pharmacy benefit manager emphasizing transparency.
By Will Maddox

Pharmaceuticals
Meet North Texas’ Award-Winning Pharmacy Influencer
Sue Ojageer wants her patients and audience to be advocates for their own health.
By Will Maddox

Pharmaceuticals
St. Vincent de Paul and the Power of Free Medicine
The nonprofit's free pharmacy is partnering with clinics across North Texas to improve medication adherence and outcomes.
By Will Maddox

Pharmaceuticals
Can ScriptCo Upend the Pharmacy Industry With an At-Cost Membership Model?
The Texas company has 2,400 members is ready to grow quickly.
By Will Maddox

Pharmaceuticals
Why Mark Cuban Put His Name on a Drug Company
The Dallas Mavericks owner has launched and funded wildly successful ventures over the years. But this time, it’s not about the money.
By Will Maddox